Interleukin 15 mediates epithelial changes in celiac disease

Gastroenterology

Volumn 119, Issue 4, 2000, Pages 996-1006

  Maiuri, Luigi ^a,b   Ciacci, Carolina ^c   Auricchio, Salvatore ^a,b   Brown, Virginia ^d   Quaratino, Sonia ^d   Londei, Marco ^b  

^a University Department of Pediatrics   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c European Laboratory for the Investigation of Food Induced Diseases   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; FAS LIGAND; GAMMA INTERFERON; GLIADIN; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR;

ADULT; APOPTOSIS; ARTICLE; CELIAC DISEASE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPT CELL; DUODENUM BIOPSY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE CELL; INTESTINE EPITHELIUM; INTESTINE VILLUS ATROPHY; MALE; NICK END LABELING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033778725     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2000.18149     Document Type: Article

References (53)

1. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue')
2. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease
3. Blockage of T-cell costimulation inhibits T-cell action in celiac disease
4. Coeliac disease
5. HLA susceptibility genes in celiac disease: Genetic mapping and role in pathogenesis
6. Epithelial cell proliferation in childhood enteropathies
7. Analysis of crypt cell proliferation in coeliac disease using MI-B1 antibody shows an increase in growth fraction
8. Increased small intestinal apoptosis in coeliac disease
9. Immunopathology of gluten-sensitive enteropathy
10. Gliadin-specific, HLA-DQ(alpha 1°0501, beta 1°0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients
11. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease
12. Exposing gliadin as a tasty food for lymphocytes
13. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients
14. Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease
15. Wheat peptide challenge in coeliac disease
16. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody
17. A major role for matrix metalloproteinases in T cell injury in the gut
18. Interleukin-2, interleukin-15, and their receptors
19. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge
20. Functional interleukin-2 receptors on intestinal epithelial cells
21. Interleukin 2 modulates intestinal epithelial cell function in vitro
22. Human intestinal epithelial cells express functional cytokine receptors sharing the common gamma c chain of the interleukin 2 receptor
23. Intestinal epithelial cells both express and respond to interleukin 15
24. IL-4 directly modulates function of a model human intestinal epithelium
25. + T cells and macrophages but no crypt-cell hyperplasia
26. Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa
27. Morphometric study of the jejunal mucosa in various childhood enteropathies with special reference to intraepithelial lymphocytes
28. Mosaic regulation of lactase in human adult-type hypolactasia
29. Human self-reactive T cell clones expressing identical T cell receptor beta chains differ in their ability to recognize a cryptic self-epitope
30. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: Implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor
31. DNA fragmentation is a feature of cystic fibrosis epithelial cells: A disease with inappropriate apoptosis
32. Crypt epithelial cells express the 4F2 antigen in untreated coeliac mucosa
33. Monoclonal antibody Ki67: Its use in histopathology
34. Epithelial proliferation in response to gastrointestinal inflammation
35. Interactions between stromal cell-derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia
36. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells
37. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens
38. Mannan and oligomers of N-acetylglucosamine protect intestinal mucosa of celiac patients with active disease from in vitro toxicity of gliadin peptides
39. Amines protect in vitro the celiac small intestine from the damaging activity of gliadin peptides
40. Toxicity mechanisms of wheat and other cereals in celiac disease and related enteropathies
41. An alternative mechanism for gluten toxicity in coeliac disease
42. Healing the epithelium: Solving the problem from two sides
43. Expression of turmour necrosis factor-alpha, interleukin-6, and interleukin-2 mRNA in the jejunum of patients with coeliac disease
44. IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops
45. Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells
46. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis
47. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis
48. Interleukin 15: A proinflammatory role in rheumatoid arthritis synovitis
49. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis
50. Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease
51. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production
52. Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: Correlation with disease activity
53. Interleukin-15 protects from lethal apoptosis in vivo